Hideaki Ayukawa

Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms

J. Furuse, Takaaki Kobayashi, N. Okano, 2021, European Journal of Drug Metabolism and Pharmacokinetics.

Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms

J. Furuse, N. Okano, T. Furuta, 2021, European Journal of Drug Metabolism and Pharmacokinetics.